| Dr Anish Wadhwa, MD | |
|
900 E Michigan Ave Ste 105, Jackson, MI 49201-2490 | |
| (517) 782-3190 | |
| Not Available |
| Full Name | Dr Anish Wadhwa |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 19 Years |
| Location | 900 E Michigan Ave Ste 105, Jackson, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235348400 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Allegiance Health | Jackson, MI | Hospital |
| Hillsdale Hospital | Hillsdale, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| W.a. Foote Memorial Hospital, Inc. | 0244136067 | 435 |
| Pulmonary Clinics Of Southern Michigan | 4284681784 | 7 |
| Hillsdale Community Health Center | 7214846260 | 48 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831123728 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000875 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629000708 PECOS PAC ID: 0244136067 Enrollment ID: O20040612000395 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | Hillsdale Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730115940 PECOS PAC ID: 7214846260 Enrollment ID: O20040805000518 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | Pulmonary Clinics Of Southern Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992818207 PECOS PAC ID: 4284681784 Enrollment ID: O20050406001085 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Entity Name | Henry Ford Wyandotte Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700145851 PECOS PAC ID: 2264334499 Enrollment ID: O20120920000394 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anish Wadhwa, MD 900 E Michigan Ave Ste 105, Jackson, MI 49201-2490 Ph: (517) 782-3190 | Dr Anish Wadhwa, MD 900 E Michigan Ave Ste 105, Jackson, MI 49201-2490 Ph: (517) 782-3190 |
News Archive
The initial success rates of the most durable surgery for a common condition in women declines over the long-term, according to data published today in the Journal of the American Medical Association.
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.'s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
During a White House ceremony next month, Thomas L. Kash, PhD, assistant professor in the department of pharmacology and the UNC Bowles Center for Alcohol Studies at the University of North Carolina at Chapel Hill School of Medicine will receive the Presidential Early Career Award for Scientists and Engineers.
› Verified 5 days ago
James Brown Chauncey Iii, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-788-4800 | |
Mrs. Bharti Sachdev, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 766 W Michigan Ave, Jackson, MI 49201 Phone: 517-784-9910 Fax: 517-787-4404 | |
Dr. Gregory A Naylor, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 Fax: 517-780-9286 | |
Rolando Manalo Beredo, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 426 N Jackson St, Jackson, MI 49201 Phone: 517-788-6336 Fax: 517-788-9035 | |
Essam Y. Tellawi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-4800 | |
Dr. Fadi Alali, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 744 W Michigan Ave Ste 201, Jackson, MI 49201 Phone: 517-205-7618 Fax: 517-205-7639 | |
Dr. Abdulbaset M. Salim, MD, MPH Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-1328 |